Figure 3.
Dynamic changes in advanced glycation end products (A) and soluble advanced glycation end product receptor (B) in ST-segment elevation myocardial infarction patients with or without diabetes (∗P < 0.05 compared to nondiabetic group; #P < 0.05 compared to Days 2 and 5).